🟢 Relay Therapeutics is trading 4.3% up today — no clear catalyst identified

Relay Therapeutics is trading 4.3% up at $18.98, with no clear company-specific or macro-driven catalyst identified for the September 22, 2026 move.

• Recent coverage described consolidation as investors await pipeline progress and year-end clinical updates.
• No company-specific announcement, earnings release, regulatory decision, partnership, or analyst action explains the move.
• The broader market is modestly positive, but major indexes do not show a sufficiently strong move to establish a clear macro-driven cause; the reason remains unconfirmed.